Webinar | December 23, 2019

A Roadmap For Early Development To Commercial Manufacturing

Source: Catalent

A key hurdle for any drug development program is bringing the drug to clinical studies. Astute companies strategize past this milestone and plan for clinical and regulatory success.  Lack of preparation for scale-up activities needed for eventual commercialization can often cause major time delays, increased costs, and a significant amount of rework. In this webcast, industry experts have presented  key topics to consider when planning for scale-up of a development program. Real-life examples to illustrate issues that have resulted in ineffective technology transfers—and strategies that can be employed to overcome these issues. Watch the webinar to learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: